109 related articles for article (PubMed ID: 31743132)
1. Effect of miR-196a inhibition on esophageal cancer growth in vitro.
Bai M; Dong Y; Zhou C; Sun X; Ma J; Han S
Anticancer Drugs; 2020 Feb; 31(2):169-176. PubMed ID: 31743132
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of miR-196a affects esophageal cancer cell growth in vitro.
Ma Y; Wang B; Guo Y; Zhang Y; Huang S; Bao X; Bai M
Biomed Pharmacother; 2016 Dec; 84():22-27. PubMed ID: 27621035
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth.
Wang K; Li J; Xiong G; He G; Guan X; Yang K; Bai Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):1151-1157. PubMed ID: 29170131
[TBL] [Abstract][Full Text] [Related]
4. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
Fendereski M; Zia MF; Shafiee M; Safari F; Saneie MH; Tavassoli M
Cancer Invest; 2017 Feb; 35(2):78-84. PubMed ID: 28095062
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
9. miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.
Zhang J; Zheng F; Yu G; Yin Y; Lu Q
Biochem Biophys Res Commun; 2013 Nov; 440(4):582-8. PubMed ID: 24120501
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
Li HL; Xie SP; Yang YL; Cheng YX; Zhang Y; Wang J; Wang Y; Liu DL; Chen ZF; Zhou YN; Wu HY
Asian Pac J Cancer Prev; 2015; 16(5):1781-7. PubMed ID: 25773825
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p.
Zhong F; Zhang W; Cao Y; Wen Q; Cao Y; Lou B; Li J; Shi W; Liu Y; Luo R; Chen C
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1190-1199. PubMed ID: 30383193
[TBL] [Abstract][Full Text] [Related]
13. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells.
Liu M; Du Y; Gao J; Liu J; Kong X; Gong Y; Li Z; Wu H; Chen H
Pancreas; 2013 Oct; 42(7):1169-81. PubMed ID: 24048456
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.
Liu Q; Bai W; Huang F; Tang J; Lin X
Int J Biochem Cell Biol; 2019 Oct; 115():105571. PubMed ID: 31352088
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).
Maxhimer JB; Reddy RM; Zuo J; Cole GW; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):53-63. PubMed ID: 15632825
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑34a inhibits esophageal squamous cell carcinoma progression by targeting E2F5.
Jiang H; Guo Y; Huang K; Lu R; Peng X; Lin S
J BUON; 2019; 24(6):2514-2522. PubMed ID: 31983127
[TBL] [Abstract][Full Text] [Related]
18. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1).
Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W
Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
20. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
